drugset / Trial / NCT03006003
Osteoporosis Treatment in Post-menopausal Women
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The study will be conducted to assess the depressive symptoms and related markers in the postmenopausal female after anti-osteoporosis treatment.
Timeline
- Start
- 2017-01-01
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alendronic Acid | Small molecule | 70 mg | — |
| Subject | Raloxifene | Other / unclassified | — | Oral |
| Comparator | Cholecalciferol | Other / unclassified | 70 ug | — |